eISSN: 1897-4252
ISSN: 1731-5530
Kardiochirurgia i Torakochirurgia Polska/Polish Journal of Thoracic and Cardiovascular Surgery
Current issue Archive Manuscripts accepted About the journal Supplements Editorial board Reviewers Abstracting and indexing Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2013
vol. 10
 
Share:
Share:
abstract:

CARDIAC SURGERY
Interventional treatment of moderate and severe mitral stenosis

Tomasz Bochenek
,
Michał Lelek
,
Magdalena Mizia
,
Marek Grabka
,
Anna Rybicka-Musialik
,
Katarzyna Mizia-Stec

Kardiochirurgia i Torakochirurgia Polska 2013; 10 (2): 110–114
Online publish date: 2013/07/09
View full text Get citation
 
PlumX metrics:
Mitral valve stenosis (MS) is becoming relatively rare. However, it was revealed in 12.1% of Euro Heart Survey participants suffering from single native left-sided valve diseases; most of these MS cases were rheumatic in origin. Echocardiographic study is a gold diagnostic standard for MS, and it includes transthoracic, transesophageal, and three dimensional evaluation. Accurate echocardiographic assessment has therapeutic implications. Interventional treatment should be considered in symptomatic patients with moderate to severe mitral stenosis (mitral valve area [MVA] ≤ 1.5 cm2). Currently, percutaneous mitral commissurotomy (PMC) is the recommended method of treatment; the safety and efficacy of this procedure are particularly dependent on echocardiographic evaluation. According to the current ESC guidelines, a surgical approach is recommended primarily in cases in which there are contraindications to PMC. In the study presented below, we describe the current guidelines for the interventional treatment of the defect, the practical aspects of qualifying patients for PMC, and the rules for performing PMC.
keywords:

mitral stenosis, percutaneous valvuloplasty, echocardiography

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.